Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Gene Therapy for Ovarian Cancer market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Gene Therapy for Ovarian Cancermarket, defines the market attractiveness level of Gene Therapy for Ovarian Cancer market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Gene Therapy for Ovarian Cancer industry, describes the types of Gene Therapy for Ovarian Cancer market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gene Therapy for Ovarian Cancer market and the development prospects and opportunities of Gene Therapy for Ovarian Cancer industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gene Therapy for Ovarian Cancer market in Chapter 13.
By Player:
VBL Therapeutics
CELSION
Takara Bio
Targovax
By Type:
Intravenous
Intratumoral
Intraperitoneal
By End-User:
Ovarian Cancer (unspecified)
Recurrent Ovarian Epithelial Cancer
Platinum-Resistant Ovarian Cancer
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Gene Therapy for Ovarian Cancer Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Gene Therapy for Ovarian Cancer Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Gene Therapy for Ovarian Cancer Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Gene Therapy for Ovarian Cancer Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Gene Therapy for Ovarian Cancer Market Analysis and Outlook to 2022
-
7.1 Global Gene Therapy for Ovarian Cancer Consumption (2017-2022)
-
7.2 United States Gene Therapy for Ovarian Cancer Consumption (2017-2022)
-
7.3 Europe Gene Therapy for Ovarian Cancer Consumption (2017-2022)
-
7.4 China Gene Therapy for Ovarian Cancer Consumption (2017-2022)
-
7.5 Japan Gene Therapy for Ovarian Cancer Consumption (2017-2022)
-
7.6 India Gene Therapy for Ovarian Cancer Consumption (2017-2022)
-
7.7 South Korea Gene Therapy for Ovarian Cancer Consumption (2017-2022)
8 Region and Country-wise Gene Therapy for Ovarian Cancer Market Analysis and Outlook to 2028
-
8.1 Global Gene Therapy for Ovarian Cancer Consumption Forecast (2022-2028)
-
8.2 United States Gene Therapy for Ovarian Cancer Consumption Forecast (2022-2028)
-
8.3 Europe Gene Therapy for Ovarian Cancer Consumption Forecast (2022-2028)
-
8.4 China Gene Therapy for Ovarian Cancer Consumption Forecast (2022-2028)
-
8.5 Japan Gene Therapy for Ovarian Cancer Consumption Forecast (2022-2028)
-
8.6 India Gene Therapy for Ovarian Cancer Consumption Forecast (2022-2028)
-
8.7 South Korea Gene Therapy for Ovarian Cancer Consumption Forecast (2022-2028)
9 Global Gene Therapy for Ovarian Cancer Market Outlook by Types and Applications to 2022
-
9.1 Global Gene Therapy for Ovarian Cancer Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Intravenous Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Intratumoral Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Intraperitoneal Consumption and Growth Rate (2017-2022)
-
9.2 Global Gene Therapy for Ovarian Cancer Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Ovarian Cancer (unspecified) Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Recurrent Ovarian Epithelial Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Platinum-Resistant Ovarian Cancer Consumption and Growth Rate (2017-2022)
10 Global Gene Therapy for Ovarian Cancer Market Outlook by Types and Applications to 2028
-
10.1 Global Gene Therapy for Ovarian Cancer Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Intravenous Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Intratumoral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Intraperitoneal Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Gene Therapy for Ovarian Cancer Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Ovarian Cancer (unspecified) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Recurrent Ovarian Epithelial Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Platinum-Resistant Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
11 Global Gene Therapy for Ovarian Cancer Import and Export Analysis (Top 5 Countries)
-
11.1 Global Gene Therapy for Ovarian Cancer Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Gene Therapy for Ovarian Cancer Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Gene Therapy for Ovarian Cancer Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Gene Therapy for Ovarian Cancer Market Competitive Analysis
-
14.1 VBL Therapeutics
-
14.1.1 VBL Therapeutics Company Details
-
14.1.2 VBL Therapeutics Gene Therapy for Ovarian Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 VBL Therapeutics Gene Therapy for Ovarian Cancer Product and Service
-
14.2 CELSION
-
14.2.1 CELSION Company Details
-
14.2.2 CELSION Gene Therapy for Ovarian Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 CELSION Gene Therapy for Ovarian Cancer Product and Service
-
14.3 Takara Bio
-
14.3.1 Takara Bio Company Details
-
14.3.2 Takara Bio Gene Therapy for Ovarian Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Takara Bio Gene Therapy for Ovarian Cancer Product and Service
-
14.4 Targovax
-
14.4.1 Targovax Company Details
-
14.4.2 Targovax Gene Therapy for Ovarian Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Targovax Gene Therapy for Ovarian Cancer Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Gene Therapy for Ovarian Cancer
-
Figure Gene Therapy for Ovarian Cancer Picture
-
Table Global Gene Therapy for Ovarian Cancer Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gene Therapy for Ovarian Cancer Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gene Therapy for Ovarian Cancer Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Gene Therapy for Ovarian Cancer Consumption by Country (2017-2022)
-
Figure United States Gene Therapy for Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Table Europe Gene Therapy for Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Figure China Gene Therapy for Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Figure Japan Gene Therapy for Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Figure India Gene Therapy for Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gene Therapy for Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Therapy for Ovarian Cancer Consumption Forecast by Country (2022-2028)
-
Figure United States Gene Therapy for Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gene Therapy for Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Gene Therapy for Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gene Therapy for Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gene Therapy for Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gene Therapy for Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intravenous Consumption and Growth Rate (2017-2022)
-
Figure Global Intratumoral Consumption and Growth Rate (2017-2022)
-
Figure Global Intraperitoneal Consumption and Growth Rate (2017-2022)
-
Figure Global Ovarian Cancer (unspecified) Consumption and Growth Rate (2017-2022)
-
Figure Global Recurrent Ovarian Epithelial Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Platinum-Resistant Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Intravenous Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intratumoral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intraperitoneal Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ovarian Cancer (unspecified) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Recurrent Ovarian Epithelial Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Platinum-Resistant Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Gene Therapy for Ovarian Cancer Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Gene Therapy for Ovarian Cancer Export by Region (Top 5 Countries) (2017-2028)
-
Table VBL Therapeutics (Foundation Year, Company Profile and etc.)
-
Table VBL Therapeutics Gene Therapy for Ovarian Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table VBL Therapeutics Gene Therapy for Ovarian Cancer Product and Service
-
Table CELSION (Foundation Year, Company Profile and etc.)
-
Table CELSION Gene Therapy for Ovarian Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table CELSION Gene Therapy for Ovarian Cancer Product and Service
-
Table Takara Bio (Foundation Year, Company Profile and etc.)
-
Table Takara Bio Gene Therapy for Ovarian Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takara Bio Gene Therapy for Ovarian Cancer Product and Service
-
Table Targovax (Foundation Year, Company Profile and etc.)
-
Table Targovax Gene Therapy for Ovarian Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Targovax Gene Therapy for Ovarian Cancer Product and Service
-
